NewsAvenda Health’s Unfold AI™ Shown to More Precisely Predict Extraprostatic Extension Risk in Prostate Cancer Patients, Surpassing Conventional MethodologyApril 27, 2023
NewsAvenda Health Announces First Commercial Use of Unfold AI on Prostate Cancer Patients in the U.S.April 25, 2023
NewsProstate Cancer Technology Startup, Avenda Health, Partnering with BioscienceLA to Establish New Life Sciences Innovation Hub in U.S.April 19, 2023
PublicationsA Novel AI – Derived Metric Identifies Favorable Candidates of Focal Therapy of Prostate Cancer and Accurately Predicts Treatment Margin EfficacyMarch 13, 2023
PublicationsDefining Prostate Cancer Focal Therapy Treatment Margins with a Machine Learning Model: Improvement Upon Hemi-Gland AblationMarch 13, 2023
NewsFirst AI-Powered Precision Oncology Platform for Prostate Cancer Care, iQuest Receives FDA ClearanceDecember 13, 2022